Arix Bioscience - Interview with Harpoon Therapeutics CEO Jerry McMahon

Jerry McMahon discusses Harpoon's novel antibody-derived platform which has been designed to use t-cells to target and destroy solid tumors in prostate, ovarian, pancreatic and other solid cancers.

Arix Bioscience
Management Team

Company Events - ARIX BIOSCIENCE